Elucidation of molecular-targeted drug resistance mechanism by lung cancer cells - EurekAlert

Elucidation of molecular-targeted drug resistance mechanism by lung cancer cells  EurekAlert

We revealed that ALK-positive lung cancer cells, treated with crizonitib, a molecular target drug, acquired resistance to the drug not only by genetic mutation but ...